118 related articles for article (PubMed ID: 9291876)
1. Developing a population-based registry for patients with paraproteinemias or multiple myeloma.
Ong F; Hermans J; Noordijk EM; de Kieviet W; Wijermans PW; Seelen PJ; Snijder S; Oostindiër MJ; Kluin-Nelemans JC
J Clin Epidemiol; 1997 Aug; 50(8):909-15. PubMed ID: 9291876
[TBL] [Abstract][Full Text] [Related]
2. [The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West].
Schaar CG; Ong F; Snijder S; Wijermans PW; Franck PF; Kluin-Nelemans JC
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1591-5. PubMed ID: 9763839
[TBL] [Abstract][Full Text] [Related]
3. Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myeloma.
Ong F; Hermans J; Noordijk EM; De Kieviet W; Seelen PJ; Wijermans PW; Kluin-Nelemans JC
Leuk Lymphoma; 1997 Nov; 27(5-6):495-501. PubMed ID: 9477131
[TBL] [Abstract][Full Text] [Related]
4. Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.
Ong F; Hermans J; Noordijk EM; Kluin-Nelemans JC
Ann Hematol; 1995 Jan; 70(1):19-24. PubMed ID: 7827202
[TBL] [Abstract][Full Text] [Related]
5. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
Ogmundsdóttir HM; Haraldsdóttirm V; Jóhannesson GM; Olafsdóttir G; Bjarnadóttir K; Sigvaldason H; Tulinius H
Haematologica; 2005 Jan; 90(1):66-71. PubMed ID: 15642671
[TBL] [Abstract][Full Text] [Related]
6. Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes.
Ong F; Kaiser U; Seelen PJ; Hermans J; Wijermans PW; de Kieviet W; Jaques G; Kluin-Nelemans JC
Blood; 1996 Jan; 87(2):712-6. PubMed ID: 8555495
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical and clinical characteristic of series of 516 paraproteinemic patients.
Tichý M; Hrncir Z; Mracek J; Hrncirová L; Matĕja F
Neoplasma; 1978; 25(4):477-81. PubMed ID: 99675
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
Lolin YI; Chow J; Wickham NW
Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
[TBL] [Abstract][Full Text] [Related]
9. Myeloma and other paraproteinemias.
Bonnet JD
Postgrad Med; 1977 Feb; 61(2):216-20. PubMed ID: 401995
[TBL] [Abstract][Full Text] [Related]
10. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
Buiting AM; Wijermans PW
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
[TBL] [Abstract][Full Text] [Related]
11. Czech Registry of Monoclonal Gammopathies - Technical Solution, Data Collection and Visualisation.
Brozova L; Schwarz D; Snabl I; Kalina J; Pavlickova B; Komenda M; Jarkovský J; Němec P; Horinek D; Stefanikova Z; Pour L; Hájek R; Maisnar V
Klin Onkol; 2017; 30(Supplementum2):43-50. PubMed ID: 28903570
[TBL] [Abstract][Full Text] [Related]
12. [Management in paraproteinemia].
Sonneveld P; Löwenberg B
Ned Tijdschr Geneeskd; 1992 Feb; 136(8):384-5. PubMed ID: 1538819
[No Abstract] [Full Text] [Related]
13. Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry.
Bergin K; Moore E; McQuilten Z; Wood E; Augustson B; Blacklock H; Ho J; Horvath N; King T; McNeil J; Mollee P; Quach H; Reid CM; Rosengarten B; Walker P; Spencer A
BMC Med Res Methodol; 2016 Nov; 16(1):151. PubMed ID: 27829380
[TBL] [Abstract][Full Text] [Related]
14. A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands.
Ong F; Hermans J; Noordijk EM; Wijermans PW; Seelen PJ; de Kieviet W; Gerrits WB; Kluin PM; Kluin-Nelemans JC
Br J Haematol; 1997 Dec; 99(4):914-20. PubMed ID: 9432042
[TBL] [Abstract][Full Text] [Related]
15. [The paraproteinemias. Clinico-biological study of hospital cases].
Monti G; Cereda UG; Motta M; Borghi A; Barberi G
Minerva Med; 1980 Oct; 71(39):2803-14. PubMed ID: 6776447
[TBL] [Abstract][Full Text] [Related]
16. [Rare forms of paraproteinemic hemoblastosis].
Andreeva NE
Ter Arkh; 1984; 56(6):59-63. PubMed ID: 6433500
[TBL] [Abstract][Full Text] [Related]
17. [A plasmacytoma with changing paraproteinemia].
Heilmann E; Schuckall A; Intorp H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(6):750-3. PubMed ID: 85587
[TBL] [Abstract][Full Text] [Related]
18. [PARAPROTEINEMIA IN MALIGNANT RETICULOSIS. REVIEW OF THE PROBLEM AND OUR EXPERIENCE WITH 9 CASES OF MULTIPLE MYELOMA].
NIKOLIC B; NIKOLIC V; PAVLOVIC KENTERA V; STEFANOVIC S
Srp Arh Celok Lek; 1963 Apr; 91():359-70. PubMed ID: 14065615
[No Abstract] [Full Text] [Related]
19. [IDIOPATHIC PARAPROTEINEMIA].
RADL J; MASOPUST J
Schweiz Med Wochenschr; 1964 Jul; 94():961-7. PubMed ID: 14243599
[No Abstract] [Full Text] [Related]
20. Hypophosphatemia associated with paraproteinemia: a case report and review of the literature.
Kerr S; Kindt J; Daram SR
WMJ; 2007 Dec; 106(8):490-3. PubMed ID: 18237074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
